Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Change in Account Payables (2016 - 2025)

Avalo Therapeutics filings provide 12 years of Change in Account Payables readings, the most recent being -$337000.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 77.95% to -$337000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$146000.0, a 10.43% increase, with the full-year FY2025 number at -$146000.0, up 10.43% from a year prior.
  • Change in Account Payables hit -$337000.0 in Q4 2025 for Avalo Therapeutics, up from -$1.9 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $9.3 million in Q1 2021 to a low of -$9.7 million in Q2 2021.
  • Median Change in Account Payables over the past 5 years was -$80500.0 (2021), compared with a mean of -$121800.0.
  • The widest YoY moves for Change in Account Payables: up 3620.72% in 2021, down 5651.79% in 2021.
  • Avalo Therapeutics' Change in Account Payables stood at -$198000.0 in 2021, then skyrocketed by 824.75% to $1.4 million in 2022, then tumbled by 123.83% to -$342000.0 in 2023, then plummeted by 346.78% to -$1.5 million in 2024, then surged by 77.95% to -$337000.0 in 2025.
  • The last three reported values for Change in Account Payables were -$337000.0 (Q4 2025), -$1.9 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.